Cross-Species Array Comparative Genomic Hybridization Identifies Novel Oncogenic Events in Zebrafish and Human Embryonal Rhabdomyosarcoma

• Eleanor Y. Chen ,

  Contributed equally to this work with: Eleanor Y. Chen, Kimberly P. Dobrinski, Kim H. Brown

  Affiliations Division of Molecular Pathology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, Harvard Stem Cell Institute, Boston, Massachusetts, United States of America, Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Kimberly P. Dobrinski ,

  Contributed equally to this work with: Eleanor Y. Chen, Kimberly P. Dobrinski, Kim H. Brown

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Pathology and Cell Biology, College of Medicine, University of Southern Florida, Tampa, Florida, United States of America

  ⨯
• Kim H. Brown ,

  Contributed equally to this work with: Eleanor Y. Chen, Kimberly P. Dobrinski, Kim H. Brown

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Biology, Portland State University, Portland, Oregon, United States of America

  ⨯
• Ryan Clagg,

  Affiliations Division of Molecular Pathology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, Harvard Stem Cell Institute, Boston, Massachusetts, United States of America, Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Elena Edelman,

  Affiliation Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Myron S. Ignatius,

  Affiliations Division of Molecular Pathology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, Harvard Stem Cell Institute, Boston, Massachusetts, United States of America, Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jin Yun Helen Chen,

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• Jillian Brockmann,

  Affiliation Division of Molecular Pathology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• G. Petur Nielsen,

  Affiliation Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Sridhar Ramaswamy,

  Affiliations Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Charles Keller,

  Affiliation Pediatric Cancer Biology Program, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon, United States of America

  ⨯
• Charles Lee,

  Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

  ⨯
• David M. Langenau

  * E-mail: dlangenau@partners.org

  Affiliations Division of Molecular Pathology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America, Harvard Stem Cell Institute, Boston, Massachusetts, United States of America, Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯